Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

VC Roundup: 2Q Financings Fall As Per-Company Averages Rise

Executive Summary

Second quarter venture capital investment in biotech fell from the same period a year ago, but the total remains near record levels, since some early-stage companies have been able to raise big VC sums.

Advertisement

Related Content

Venture Funding Deals: Cell Medica Raises $73.2m, Tango Dances In With $55m
Finance Watch: OncoMed Cuts Costs To Conserve Capital While Public, Private Peers Raise Cash
VC Roundup: 2016 US Investment Ends On A Down Note, But Biopharma Has Second-Best Year
Biotech VC Funding Rises As Fewer Companies Get More Dollars
ASLAN Keeps Eye On Maximizing Values After Fundraising
Epizyme Appoints CEO
Allergan buys chin fat firm Kythera for $2.1bn
BioNotebook: Second Genome/Pfizer, Merck/Agenus, Endo/Somar, Parion/Gilead, Lightstone Ventures, Kite Pharma, five IPO updates
J&J enters deal with Second Genome to study gut bacteria
The Unlikely Renaissance Of Gene Therapy

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC096938

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel